|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.940 USD | +2.11% |
|
+4.86% | +41.61% |
| Market Cap | 670M 577M 531M 498M 936M 63.28B 945M 6.28B 2.45B 30.99B 2.51B 2.46B 107B | P/E Ratio 2026 * |
-2.76x | P/E Ratio 2027 * | -2.59x |
|---|---|---|---|---|---|
| Enterprise Value | 484M 417M 384M 360M 676M 45.73B 683M 4.54B 1.77B 22.4B 1.82B 1.78B 77.5B | EV / Sales 2026 * |
80,653x | EV / Sales 2027 * | 43.8x |
| Free-Float |
83.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Allogene Therapeutics, Inc.
| 1 day | +2.11% | ||
| 1 week | +4.86% | ||
| Current month | -10.60% | ||
| 1 month | -3.00% | ||
| 3 months | -19.17% | ||
| 6 months | +31.97% | ||
| Current year | +41.61% |
| 1 week | 1.75 |  | 2.1 |
| 1 month | 1.75 | | 2.32 |
| Current year | 1.31 | | 4.46 |
| 1 year | 0.98 | | 4.46 |
| 3 years | 0.86 | | 6.05 |
| 5 years | 0.86 | | 27.86 |
| 10 years | 0.86 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Chang
CEO | Chief Executive Officer | 66 | 01/06/2018 |
Geoffrey Parker
DFI | Director of Finance/CFO | 61 | 16/10/2023 |
Benjamin Beneski
CTO | Chief Tech/Sci/R&D Officer | 49 | 28/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Arie Belldegrun
CHM | Chairman | 76 | 01/11/2017 |
David Chang
BRD | Director/Board Member | 66 | 01/06/2018 |
Joshua Kazam
BRD | Director/Board Member | 49 | 01/11/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-21 | Sell | Controller/Auditor | 9,586 | 0.0039% | ||
| 03-31 | Sell | Chief Technology Officer | 2,867 | 0.0013% | ||
| 03-16 | Sell | Founder | 47,763 | 0.0213% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.11% | +4.86% | +44.78% | -60.97% | 670M | |
| -0.24% | +0.18% | +57.19% | +108.17% | 54.92B | |
| -0.34% | +3.51% | +45.55% | +40.16% | 44.31B | |
| +0.29% | +6.20% | -14.80% | -19.65% | 22.96B | |
| -0.40% | +3.49% | -1.29% | +387.06% | 21.12B | |
| -2.91% | +0.27% | +13.28% | -36.73% | 16.31B | |
| -1.35% | -2.24% | +6.78% | -41.18% | 15.19B | |
| -0.24% | +2.44% | +27.43% | +177.49% | 13.32B | |
| +1.48% | +9.81% | +19.29% | - | 12.48B | |
| +0.32% | +2.81% | +96.37% | +213.49% | 11.21B | |
| Average | -0.14% | +2.97% | +29.46% | +85.31% | 21.25B | |
| Weighted average by Cap. | -0.38% | +2.86% | +32.14% | +94.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6K 5.17K 4.76K 4.46K 8.39K 567K 8.47K 56.27K 21.98K 278K 22.52K 22.04K 961K | 12.97M 11.18M 10.29M 9.65M 18.13M 1.23B 18.32M 122M 47.52M 600M 48.68M 47.65M 2.08B |
| Net income | -197M -169M -156M -146M -275M -18.58B -278M -1.84B -720M -9.1B -738M -722M -31.48B | -227M -196M -180M -169M -318M -21.47B -321M -2.13B -832M -10.51B -852M -834M -36.38B |
| Net Debt | -186M -160M -147M -138M -260M -17.55B -262M -1.74B -680M -8.59B -697M -682M -29.74B | -101M -86.88M -79.96M -75.01M -141M -9.53B -142M -945M -369M -4.66B -378M -370M -16.14B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/06/26 | 1.940 $ | +2.11% | 5,800,150 |
| 12/06/26 | 1.900 $ | +1.06% | 8,642,431 |
| 11/06/26 | 1.880 $ | +5.62% | 6,102,343 |
| 10/06/26 | 1.780 $ | -2.20% | 7,943,853 |
| 09/06/26 | 1.820 $ | -1.62% | 7,723,891 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALLO Stock
Select your edition
All financial news and data tailored to specific country editions
